Security key
035255108
Anika Therapeutics, Inc. - Common Stock (ANIK)
CUSIP: 035255108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,685,136
- Total 13F value
- $134,203,655
- Share change
- +13,860
- SEC-reported price per share
- $10.58
- Number of holders
- 101
- Value change
- -$1,529,085
- Number of buys
- 52
- Number of sells
- 53
- Shares outstanding
- 13,404,566
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
101
Top holders
10
ANIK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Anika Therapeutics, Inc. SEC filings
Anika Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 035255108
Recent filing periods:
Ownership snapshot
Top reported holders of ANIK - Anika Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
Trigran Investments, Inc.
Comparable rows
15/15
Latest evidence
20 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 6.8%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 6.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
6.8%
DIMENSIONAL FUND ADVISORS LP
4.5%
Glenn R. Larsen
0.37%
Susan L. N. Vogt
0.37%
William R. Jellison
0.17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$22,834,493
1,519,261 shares
|
— | 31 Mar 2025 |
| DIMENSIONAL FUND ADVISORS LP |
13D/G
13F
Company
|
4.5%
|
$9,656,545
657,355 shares
|
$0 | 31 Dec 2024 |
| Glenn R. Larsen |
3/4/5
Director
|
0.37%
|
$564,899
50,258 shares
|
— | 20 Jun 2025 |
| Susan L. N. Vogt |
3/4/5
Director
|
0.37%
|
$564,394
50,213 shares
|
— | 20 Jun 2025 |
| William R. Jellison |
3/4/5
Director
|
0.17%
|
$259,677
23,103 shares
|
— | 20 Jun 2025 |
| Trigran Investments, Inc. |
13F
Company
|
15%
|
$30,689,051
2,041,853 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
101
Shares
12,685,136
Rows available
101
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
107
Q2 2025 holders
101
Holder diff
-6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend